| Literature DB >> 30216975 |
Xixia Liu1, Qi Lu2, Sirui Chen3, Fang Wang4, Jianjun Hou5, Zhenlin Xu6, Chen Meng7, Tianyuan Hu8, Yaoyao Hou9.
Abstract
We describe a multiple combined strategy to discover novel aptamers specific for clenbuterol (CBL). An immobilized ssDNA library was used for the selection of specific aptamers using the systematic evolution of ligands by exponential enrichment (SELEX). Progress was monitored using real-time quantitative PCR (Q-PCR), and the enriched library was sequenced by high-throughput sequencing. Candidate aptamers were picked and preliminarily identified using a gold nanoparticles (AuNPs) biosensor. Bioactive aptamers were characterized for affinity, circular dichroism (CD), specificity and sensitivity. The Q-PCR amplification curve increased and the retention rate was about 1% at the eighth round. Use of the AuNPs biosensor and CD analyses determined that six aptamers had binding activity. Affinity analysis showed that aptamer 47 had the highest affinity (Kd = 42.17 ± 8.98 nM) with no cross reactivity to CBL analogs. Indirect competitive enzyme linked aptamer assay (IC-ELAA) based on a 5'-biotin aptamer 47 indicated the limit of detection (LOD) was 0.18 ± 0.02 ng/L (n = 3), and it was used to detect pork samples with a mean recovery of 83.33⁻97.03%. This is the first report of a universal strategy including library fixation, Q-PCR monitoring, high-throughput sequencing, and AuNPs biosensor identification to select aptamers specific for small molecules.Entities:
Keywords: aptamers; clenbuterol; gold nanoparticles biosensor; high-throughput sequencing technology; real-time quantitative PCR; systematic evolution of ligands by exponential enrichment
Mesh:
Substances:
Year: 2018 PMID: 30216975 PMCID: PMC6225122 DOI: 10.3390/molecules23092337
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1The quantitative standard curve of Q-PCR.
Figure 2Q-PCR monitoring of the selection process: (A) amplification curve of Q-PCR for each round of selection; and (B) retention rate for each round of selection.
Figure 3Preliminarily selection of active aptamers using the AuNPs biosensor.
Sequence (5′−3′), dissociation constant (Kd) and dG values of aptamer candidates.
| No. | Sequences | Kd (nM) | dG |
|---|---|---|---|
| 28 | 5′ACGCATAGGATGCAACAACGCGAATGCCACCAATTCGTGCTTGTCGTGTCCTATGCGT3′ | 321 ± 104.5 | −15.09 |
| 47 | 5′ACGCATAGGTCATGCCAAGCTGTACACCGTCCTGGCCTGGTTGGGATGTCCTATGCGT3′ | 42.17 ± 8.98 | −13.76 |
| 64 | 5′ACGCATAGGTACACCACATCGGATCGTAATGCGTATGTGACTCAGTGTGCCTATGCGT3′ | 123.3 ± 14.28 | −16.26 |
| 78 | 5′ACGCATAGGGTACGCCACAGATCGACCTCTGGTTGGTCCTGTTGTGTGGCCTATGCGT3′ | 201.1 ± 42.42 | −16.00 |
| 132 | 5′ACGCATAGGGACCATGCGCAGTGAACTTGGTTCTTTGTGCTCATGTGTGCCTATGCGT3′ | 221.6 ± 41.87 | −14.77 |
| 154 | 5′ACGCATAGGGCATCACACATGTCCTTGCCATTGCTGACTTGTTTGGTGTCCTATGCGT3′ | 268.8 ± 40.43 | −15.40 |
Figure 4The secondary structure predicted by mfold and corresponding saturation curve of aptamer 47.
Figure 5CD spectrum identification of binding activity between six aptamers and CBL.
Figure 6Identification of the specificity of six active aptamers against CBL.
Figure 7Standard curve for CBL detection: (A) standard curve for CBL detection with aptamer 47 using AuNPs biosensor; and (B) standard curve for CBL detection with 5′-biotin aptamer 47 using ic-ELAA.
Recovery test results with pork samples (n = 3).
| Samples | Spiked Concentration (ng/g) | Detection Concentration | Recovery (%) | RSD (%) |
|---|---|---|---|---|
| Pork | 1 | 0.83 ± 0.02 | 83.33 ± 1.53 | 1.83 |
| 5 | 4.66 ± 0.09 | 93.27 ± 1.70 | 1.82 | |
| 10 | 9.70 ± 0.05 | 97.03 ± 0.45 | 0.46 |
Primer sequences.
| Name | Sequences (5′-3′) |
|---|---|
| Biotin-P | 5 |
| FAM-Forward | 6-FAM-5 |
| polyA-Reverse | 5 |
| Q-Forward | 5 |
| Q-Reverse | 5 |
Figure 8Graphical abstract.